Ameriprise’s Xeris Biopharma Holdings XERS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $696K | Sell |
149,028
-19,074
| -11% | -$89.1K | ﹤0.01% | 3380 |
|
|
2025
Q1 | $923K | Sell |
168,102
-41,821
| -20% | -$230K | ﹤0.01% | 3214 |
|
|
2024
Q4 | $712K | Sell |
209,923
-7,166
| -3% | -$24.3K | ﹤0.01% | 3369 |
|
|
2024
Q3 | $619K | Sell |
217,089
-2,817
| -1% | -$8.03K | ﹤0.01% | 3402 |
|
|
2024
Q2 | $495K | Sell |
219,906
-733,330
| -77% | -$1.65M | ﹤0.01% | 3413 |
|
|
2024
Q1 | $2.11M | Buy |
953,236
+433,115
| +83% | +$957K | ﹤0.01% | 2844 |
|
|
2023
Q4 | $1.22M | Sell |
520,121
-67,817
| -12% | -$159K | ﹤0.01% | 3110 |
|
|
2023
Q3 | $1.09M | Sell |
587,938
-4,570
| -0.8% | -$8.5K | ﹤0.01% | 3099 |
|
|
2023
Q2 | $1.55M | Buy |
592,508
+23,261
| +4% | +$60.9K | ﹤0.01% | 2992 |
|
|
2023
Q1 | $928K | Sell |
569,247
-820
| -0.1% | -$1.34K | ﹤0.01% | 3185 |
|
|
2022
Q4 | $758K | Hold |
570,067
| – | – | ﹤0.01% | 3252 |
|
|
2022
Q3 | $890K | Buy |
570,067
+156,573
| +38% | +$244K | ﹤0.01% | 3169 |
|
|
2022
Q2 | $638K | Sell |
413,494
-4,270
| -1% | -$6.59K | ﹤0.01% | 3308 |
|
|
2022
Q1 | $1.07M | Buy |
417,764
+367,163
| +726% | +$940K | ﹤0.01% | 3187 |
|
|
2021
Q4 | $168K | Buy |
50,601
+2,401
| +5% | +$7.97K | ﹤0.01% | 3807 |
|
|
2021
Q3 | $118K | Sell |
48,200
-400
| -0.8% | -$979 | ﹤0.01% | 3766 |
|
|
2021
Q2 | $198K | Buy |
48,600
+4,905
| +11% | +$20K | ﹤0.01% | 3752 |
|
|
2021
Q1 | $197K | Buy |
43,695
+33,680
| +336% | +$152K | ﹤0.01% | 3705 |
|
|
2020
Q4 | $49K | Sell |
10,015
-7,095
| -41% | -$34.7K | ﹤0.01% | 3720 |
|
|
2020
Q3 | $101K | Buy |
+17,110
| New | +$101K | ﹤0.01% | 3636 |
|